. . . . . . . . "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." . . . . . . "Adults" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "N+QrDfUeXeC9094qWUFtBnZZvi25I8IYl6Cf7OBpY7S2NX9IWw5EIkB9KkQ6armQJZub8w596VWyjf6kkGdRetIuF10NzEh5UpUC4CLTpVgMUxV1exZ6H2glFmXtXRf9mEYPNmzx2dI4peL1MqfgOBYFav53HVsofGDtohsuAzM=" . . "2021-03-29T09:55:14.342+02:00"^^ . . . . .